First test of new drug aimed at halting Cancer's devastating weight loss
Disease control
Recruiting now
This is the first-ever study in people of an experimental drug called GB18. It aims to see if the drug is safe and how it behaves in the body. The ultimate goal is to see if GB18 could one day help control the severe, debilitating weight loss (cachexia) that affects many cancer p…
Phase: PHASE1 • Sponsor: Shenzhen Kexing Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC